NewCelX Ltd. (NCEL)
2.68
+0.02
(+0.75%)
USD |
NASDAQ |
Jan 23, 16:00
2.68
0.00 (0.00%)
After-Hours: 16:16
NewCelX Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| BeOne Medicines Ltd. | -49.28M |
| AC Immune SA | 26.82M |
| CRISPR Therapeutics AG | -119.23M |
| Addex Therapeutics Ltd. | 0.0379M |
| Molecular Partners AG | 14.54M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow | -4.815M |
| Free Cash Flow Yield | -517.4% |